Cited by 7Genomics and Rare DiseasesFamily and Disability Support ResearchFamily Support in Illness

Defining the complex needs of families with rare diseases—the example of telomere biology disorders

Open access
Wilsnack, Catherine, Rising, Camella J., Pearce, Emily E., Forbes Shepherd, Rowan, Thompson, Ashley S., Majid, Alina, Werner-Lin, Allison, Savage, Sharon A. +1 more·2024·European Journal of Human Genetics

Abstract

Families with rare diseases, such as telomere biology disorders (TBDs), may have extensive unmet needs given the heterogeneity, chronicity, and potential severity of illness. TBDs are rare inherited syndromes associated with high risk of bone marrow failure, cancer, pulmonary fibrosis, and other severe, chronic complications. To identify gaps in clinical care, we aimed to ascertain the perceived unmet needs of adults and family caregivers, current or bereaved, of individuals with TBDs. Participants were aged ≥18 years with a self-reported TBD diagnosis and/or ever caregivers to one or more family members with a TBD. Participants completed an online survey (N = 35) and/or an audio-recorded telephone interview (N = 32). We calculated descriptive statistics in SPSS and thematically analyzed interview transcripts. Quantitative and qualitative data were analyzed concurrently. Most participants were aged ≥35 years, female, highly educated, and medically insured. Survey respondents reported numerous unmet needs in psychosocial, medical, financial, and daily activity domains. In interviews, participant descriptions validated and contextualized the salience of these unmet needs. Both qualitative and quantitative data identified critical shortfalls in addressing chronic family distress and specialty care coordination. Adults and caregivers of individuals with TBDs have a high risk of adverse psychosocial sequelae given extensive unmet needs. These findings provide a foundation for understanding the range and extent of gaps in care for families with rare diseases, especially TBDs but that are likely applicable to others. Tailored multi-disciplinary interventions involving patients, families, clinicians, researchers, and patient advocacy communities are required to appropriately address care needs for all rare diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41431-024-01697-6

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Consistent with Wilsnack et al. (2024), many experiences voiced by parents-uncertainty, emotional exhaustion, isolation, grief-reflect not only personal lived experience but also failure of health and social care systems to provide timely, coordinated, comprehensive support.

    “Consistent with Wilsnack et al. (2024), many of the experiences voiced by parents—including uncertainty, emotional exhaustion, isolation, and grief—reflect not only their personal lived experience of caregiving but also the failure of the health and social care systems to provide timely, coordinated, and comprehensive support.”

    From "I don't grieve as much as I used to": A qualitative study on parents of children with rare and undiagnosed conditions navigating grief in the context of uncertainty. (2025) · cites this paper as Wilsnack et al. (2024)

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. [2]Wakap SN, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point preference of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28:165–73. 10.1038/s41431-019-0508-0. 31527858 PMC6974615 · DOI · Paper page
  2. [3]Yang G, Cintina I, Pariser A, Oehrlein E, Sullivan J, Kennedy A. The national economic burden of rare disease in the United States in 2019. Orphanet J Rare Dis. 2022;17:163 10.1186/s13023-022-02299-5. 35414039 PMC9004040 · DOI
  3. [4]Navarrete-Opazo AA, Singh M, Tisdale A, Cutillo CM, Garrison SR. Can you hear us now? The impact of health-care utilization by rare disease patients in the United States. Genet Med. 2021;23:2194–201. 10.1038/s41436-021-01241-7. 34183788 PMC8553605 · DOI
  4. [5]Wojcik MH, Bresnahan M, Del Rosario MC, Ojeda MM, Kritzer A, Fraiman YS. Rare diseases, common barriers: disparities in pediatric clinical genetics outcomes. Pediatr Res. 2023;93:110–7. 10.1038/s41390-022-02240-3. 35963884 PMC9892172 · DOI
  5. [6]Bogart KR, Irvin VL. Health-related quality of life among adults with diverse rare disorders. Orphanet J Rare Dis. 2017;12:177 10.1186/s13023-017-0730-1. 29212508 PMC5719717 · DOI · Paper page
  6. [8]Depping MK, Uhlenbusch N, von Kodolitsch Y, Klose HFE, Mautner V-F, Löwe B. Supportive care needs of patients with rare chronic diseases: multi-method, cross-sectional study. Orphanet J Rare Dis. 2021;16:44 10.1186/s13023-020-01660-w. 33482869 PMC7825171 · DOI
  7. [9]Pelentsov LJ, Fielder AL, Laws TA, Esterman AJ. Development of the parental needs scale for rare diseases: a tool for measuring the supportive care needs of parents caring for a child with a rare disease. J Multidiscip Healthc. 2016;9:425–33. 10.2147/JMDH.S113898. 27672327 PMC5024776 · DOI
  8. [10]Dokal I, Vulliamy T, Mason P, Bessler M Clinical utility gene card for: dyskeratosis congenita - update 2015. Eur J Hum Genet. 2015;23. 10.1038/ejhg.2014.170. PMC4667501 25182133 · DOI
  9. [11]Revy P, Kannengiesser C, Bertuch AA. Genetics of human telomere biology disorders. Nat Rev Genet. 2023;24:86–108. 10.1038/s41576-022-00527-z. 36151328 · DOI
  10. [12]Savage SA. Dyskeratosis congenita and telomere biology disorders. Hematology Am Soc Hematol Educ Program. 2022;2022:637–48. 10.1182/hematology.2022000394. 36485133 PMC9821046 · DOI
  11. [13]Alter BP, Rosenberg PS, Giri N, Baerlocher GM, Lansdorp PM, Savage SA. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica. 2012;97:353–9. 10.3324/haematol.2011.055269. 22058220 PMC3291588 · DOI · Paper page
  12. [14]Niewisch MR, Giri N, McReynolds LJ, Alsaggaf R, Bhala S, Alter B, et al. Disease progression and clinical outcomes in telomere biology disorders. Blood. 2022;139:1807–19. 10.1182/blood.2021013523. 34852175 PMC8952184 · DOI
  13. [15]Ongie L, Raj HA, Barret Stevens K. Genetic counseling and family screening recommendations in patients with telomere biology disorders. Curr Hematol Malig Rep. 2023;18:273–83. 10.1007/s11899-023-00713-8. 37787873 · DOI
  14. [17]Hamilton JG, Hutson SP, Frohnmayer AE, Han PKJ, Peters JA, Carr AG, et al. Genetic information-seeking behaviors and knowledge among family members and patients with inherited bone marrow failure syndromes. J Genet Couns. 2015;24:760–70. 10.1007/s10897-014-9807-3. 25540896 PMC4485598 · DOI
  15. [18]Hamilton JG, Hutson SP, Moser RP, Kobrin SC, Frohnmayer AE, Alter BP, et al. Sources of uncertainty and their association with medical decision making: exploring mechanisms in Fanconi anemia. Ann Behav Med. 2013;46:204–16. 10.1007/s12160-013-9507-5. 23637072 · DOI
  16. [19]Hutson SP, Han PK, Hamilton JG, Rife SC, Al-Rahawan MM, Moser RP, et al. The use of haematopoietic stem cell transplantation in Fanconi anaemia patients: a survey of decision making among families in the US and Canada. Health Expect. 2015;18:929–41. 10.1111/hex.12066. 23621292 PMC3766454 · DOI
  17. [20]Zierhut HA, Bartels DM. Waiting for the next shoe to drop: the experience of parents of children with Fanconi anemia. J Genet Couns. 2012;21:45–58. 10.1007/s10897-011-9394-5. 21805222 · DOI
  18. [21]Creswell JW, Clark VLP. Designing and conducting mixed methods research. 3rd ed. Thousand Oaks, CA: Sage Publications; 2017.
  19. [22]Thorne, S. Intrepretive description: qualitative research for applied practice. 2nd ed. New York, NY: Routledge; 2016.
  20. [23]Vaughn LM, Jacquez F. Participatory research methods – choice points in the research process. J Particip Res Methods. 2020;1. 10.35844/001c.13244. · DOI
  21. [24]Kim Y, Kashy DA, Spillers RL, Evans TV. Needs assessment of family caregivers of cancer survivors: three cohorts comparison. Psychooncology. 2010;19:573–82. 10.1002/pon.1597. 19582798 · DOI
  22. [25]Kim Y, Carver CS, Cannady RS. Bereaved family cancer caregivers’ unmet needs: measure development and validation. Ann Behav Med. 2020;54:164–75. 10.1093/abm/kaz036. 31602463 PMC7344228 · DOI
  23. [26]Vroom VH. Some personality determinants of the effects of participation. J Abnorm Soc Psychol. 1959;59:322–7. · DOI
  24. [27]Clarke V, Braun V, Hayfield N. Thematic analysis. In: Smith JA, ed. Qualitative psychology: a practical guide to research methods. Thousand Oaks: Sage Publications; 2015: 222-48.
  25. [28]Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks, CA: Sage Publications; 2011.
  26. [29]Mollica MA, Smith AW, Kent EE. Caregiving tasks and unmet supportive care needs of family caregivers: a U.S. population-based study. Patient Educ Couns. 2020;103:626–34. 10.1016/j.pec.2019.10.015. 31704030 · DOI

Cited by

Sorted by citations

Authors
Wilsnack, C., Rising, C. J., Pearce, E. E., Forbes Shepherd, R., Thompson, A. S., Majid, A., Werner-Lin, A., Savage, S. A., & Hutson, S. P.
Affiliations
  • The University of Texas at Austin (US)
  • Division of Cancer Epidemiology and Genetics (US)
  • National Cancer Institute (US)
Corresponding author
Savage, Sharon A.
Venue
European Journal of Human Genetics
Published
2024-10-01
Volume
32
Issue
12
Pages
1615-1623
ISSN
  • 1018-4813 (ISSN-L)
  • 1476-5438
OpenAlex
W4403046399
Cited by
7
References
1
Citations by year
2026: 1 · 2025: 4 · 2024: 2
FWCI
1.72
Type
journal article
Language
en
Open access
Locations
  • European Journal of Human Genetics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Social Sciences › Psychology › Clinical Psychology › Family and Disability Support Research
  • Social Sciences › Sociology and Political Science › Family Support in Illness
Keywords
telomere biology disorders, rare diseases, unmet needs, family caregivers, bereaved caregivers, psychosocial needs, financial burden, care coordination, bone marrow failure, chronic disease, patient advocacy, multidisciplinary intervention
MeSH terms
Adult, Aged, Family, Female, Health Services Needs and Demand, Humans, Male, Middle Aged, Telomere, Caregivers, Rare Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review